• Drug Coverage
  • Hypertrophic Cardiomyopathy (HCM)
  • Vaccines: 2023 Year in Review
  • Eyecare
  • Urothelial Carcinoma
  • Women's Health
  • Hemophilia
  • Heart Failure
  • Vaccines
  • Neonatal Care
  • NSCLC
  • Type II Inflammation
  • Substance Use Disorder
  • Gene Therapy
  • Lung Cancer
  • Spinal Muscular Atrophy
  • HIV
  • Post-Acute Care
  • Liver Disease
  • Pulmonary Arterial Hypertension
  • Safety & Recalls
  • Biologics
  • Asthma
  • Atrial Fibrillation
  • Type I Diabetes
  • RSV
  • COVID-19
  • Cardiovascular Diseases
  • Breast Cancer
  • Prescription Digital Therapeutics
  • Reproductive Health
  • The Improving Patient Access Podcast
  • Blood Cancer
  • Ulcerative Colitis
  • Respiratory Conditions
  • Multiple Sclerosis
  • Digital Health
  • Population Health
  • Sleep Disorders
  • Biosimilars
  • Plaque Psoriasis
  • Leukemia and Lymphoma
  • Oncology
  • Pediatrics
  • Urology
  • Obstetrics-Gynecology & Women's Health
  • Opioids
  • Solid Tumors
  • Autoimmune Diseases
  • Dermatology
  • Diabetes
  • Mental Health

Teladoc Health Announces Deal With Northwell Health

Article

The company's services will be white labeled under the hospital system’s brand.

Teladoc Health ($TDOC) announced today that it struck a deal with Northwell Health to provide its Microsoft-compatiable telehealth technology to the large New York metro area healthcare system.

Teladoc has deals with other healthcare systems, but a company spokesperson said this is the first to involve Solo, its product that works with Microsoft Teams. Microsoft's teleconferencing software.

The deal, the terms of which were not disclosed, does not involve the services of clinicians that work for Teladoc. Instead, the company's telehealth technology will be “white labeled” under the Northwell Health brand and Northwell clinicians will use it to provide telehealth services to their patients.

Northwell Health, headquartered in New Hyde Park, New York, bills itself as New York State’s largest healthcare provider. The system comprises 22 hospitals, including North Shore University Hospital and Long Island Jewish Medical Center.

Teladoc’s stock was trading at $58.32 when the markets closed today, slightly down from its opening price of $59.79.

Teladoc announced in July 2021 that it had developed a product called Solo that works with Microsoft Teams, a software platform that supports teleconferencing like Zoom but also has direct messaging and scheduling functions.

Related Videos
Video 3 - "In-Office Procedures, Over-the-Counter Options, Treatment Delays, and Costs"
Video 6 - "Safety Analysis and Interpreting Results from MAJIC-PV"
Video 5 - "Key Findings from MAJIC-PV"
Video 2 - "Traditional Treatment of Demodex Blepharitis, FDA approval, and Lotilaner Ophthalmic Solution, 0.25%"
Gabriela Hobbs, MD, an expert on polycythemia vera
Gabriela Hobbs, MD, and Timothy Mok, PharmD, BCPS, BCOP
Video 1 - "Demodex Blepharitis: Prevalence, Symptoms, Quality of Life Impact, and Diagnosis"
Video 2 - "The Role of Ruxolitinib in Managing Hydroxyurea Resistance or Intolerance"
Video 1 - "Prevalence and Impact of Hydroxyurea Intolerance or Resistance in Polycythemia Vera"
Related Content
© 2024 MJH Life Sciences

All rights reserved.